Medications for Insomnia

This trial tests the effectiveness and safety of various medications for treating insomnia, a condition where individuals struggle to fall or stay asleep. The study compares several common treatments, such as zolpidem, trazodone, melatonin, and diphenhydramine, and includes doxepin, an antidepressant that might offer a better balance of benefits and risks. Individuals who have experienced significant difficulty falling or staying asleep for at least three months may qualify. Participants must discontinue any sleep-related medications before joining the trial. As a Phase 4 trial, this research involves FDA-approved treatments and aims to understand their benefits for a broader patient population.

Yes, you will need to stop taking all sleep-related medications before joining the trial. There is a required 2-week period without these medications before starting the study.

Previous studies have shown that melatonin has minimal side effects, making it generally safe for short-term use. However, long-term use might cause mild issues like headaches or dizziness. Diphenhydramine is also considered safe for short-term sleep problems in younger adults, but it may cause drowsiness and isn't recommended for older adults due to higher risks. Research on zolpidem highlights a risk of feeling drowsy the next morning, especially in older people. It is safe for short-term use but may increase the risk of falls. Studies have shown that doxepin is well-tolerated, with low doses producing good results without major side effects. Trazodone is generally safe for short-term use but can cause dry mouth or nightmares. These findings are important to consider when deciding on a treatment.¹²³⁴⁵

Researchers are excited about these treatments for insomnia because they offer a diverse range of options, targeting the condition in different ways. Unlike typical medications like benzodiazepines or newer sleep aids like Eszopiclone, this trial explores both conventional and alternative approaches. Melatonin, a natural hormone, helps regulate sleep-wake cycles without the risk of dependency. Doxepin and Trazodone, traditionally used as antidepressants, are being tested for their sedative effects at low doses, potentially offering a dual benefit of mood stabilization and sleep improvement. Meanwhile, Zolpidem, a well-known sleep aid, and Diphenhydramine, an antihistamine, are being reevaluated for their efficacy and safety, especially considering age-related concerns. This comprehensive approach aims to expand treatment possibilities for individuals struggling with insomnia.

This trial will compare various medications for insomnia, including zolpidem, doxepin, trazodone, diphenhydramine, and melatonin. Research has shown that zolpidem helps people sleep longer and fall asleep faster. Doxepin also improves sleep quality and helps maintain sleep, making it a good option for insomnia. Trazodone reduces early morning awakenings. Diphenhydramine can help with falling asleep quicker and sleeping longer, but it is not recommended for older adults and is part of a separate arm in this trial. Melatonin, also being tested, has mixed results; some studies suggest it helps with falling asleep faster, while others find little effect. These treatments work differently for everyone, but zolpidem and doxepin have shown the most consistent positive results for insomnia in previous research.¹⁶⁷⁸⁹